Daily FNArena News

A 10% profit upgrade from Mitchell (formerly emitch) suggests the group’s traditional media acquisition is performing well.

CSL has received approval for a liquid version of its IVIG compound in the US and UBS suggests the market will have to play catch up with earnings forecasts as a result.

Two acquisitions should not only strengthen Arasor’s technological position in the market, but also give its profits a boost, Patersons analyst Russell Wright says.

As the Aussie results season gets underway proper this week, we have some more data for the RBA to chew over, and a lot of data to frighten the US.

The pattern has been broken as the Dow fell another 200 points on Friday despite a strong economic growth number. The Aussie continues to be slaughtered.

There remains no broker consensus on Santos, with Buy ratings reflecting potential corporate activity and Sell ratings the stock’s current premium to valuations.

The Aussie dollar was pushed sharply lower overnight but according to Westpac Bank its uptrend against the US dollar should soon continue with US92c a year-end target.

Goldilocks fled the scene last night as exceptionally poor housing data finally overshadowed any earnings reports and credit contagion ruled the day. Carry trade unwinding began in earnest stripping more than a cent off the Aussie.

Another Australian hedge fund has suspended redemptions while an Italian bank is close to going under. And GaveKal contemplates the $5 Hermes tie.

Perseverance has delivered a quarterly in line with expectations that were hosed down a couple of weeks ago, leaving brokers to question whether the apparent value in the stock can be realised.